Alzheimer

Special Care for Alzheimer’s Patients: A Compassionate Approach

by
Special Care for Alzheimer’s Patients: A Compassionate Approach

Understanding Alzheimer’s Disease: A Growing Challenge⁢ for Aging Americans Table of Contents Understanding Alzheimer’s Disease: A Growing Challenge⁢ for Aging Americans Understanding Alzheimer’s: A Journey Thru Memory and Emotion Understanding Alzheimer’s Disease: A Conversation with Dr. Livia ⁢Dima Alzheimer’s‌ disease, a chronic neurodegenerative condition, is steadily becoming a focal point in healthcare discussions across the … Read more

Alzheimer, 190 thousand patients in Lombardy. Here are some tips to keep the disease away as much as possible

by
Alzheimer, 190 thousand patients in Lombardy. Here are some tips to keep the disease away as much as possible

Table of Contents 1 Doctors on the front line 2 The (scary) data from Lombardy 3 The trend 4 Prevention tips 5 Attributes of saffron 6 How might ⁤the ⁣cultural and social context of Lombardy influence the approaches to Alzheimer’s‌ research, patient care, and ​public perception of the disease? Milan, 27 November 2024 – With … Read more

This group is the most vulnerable to experience prolonged COVID, still sick even though they are negative

by
This group is the most vulnerable to experience prolonged COVID, still sick even though they are negative

Jakarta – Those who have previously been exposed to COVID-19 and still have symptoms six months or two years later have a lower chance of recovering from ‘Long COVID‘. Many people do not realize that they experience ‘persistent’ complaints after exposure. Quoted from the National Library of Medicine of the US National Institutes of Health … Read more

what is this promising drug developed by researchers?

by
what is this promising drug developed by researchers?

Par Editorial News Published on Oct 15, 2024 at 5:06 a.m. See my news Follow News THE Tau proteins play a crucial role in maintaining the structure and function of neurones. However, in Alzheimer’s disease, these proteins malfunction, clumping together to form long twists. These accumulations create “neurofibrillar” tangles that obstruct neurons, preventing them from … Read more

Is it possible to shower during a thunderstorm?

by
Is it possible to shower during a thunderstorm?

About 40 million lightning strikes strike the ground in the United States each year. According to the US Centers for Disease Control and Prevention (CDC), there is less than a one in a million chance of being struck by lightning directly or indirectly. While rare (and even though 90% of lightning strikes are not fatal), … Read more

Alzheimer’s: How music can help with dementia

by
Alzheimer’s: How music can help with dementia

September 21st is – like every year – World Alzheimer’s Day. On that day, events such as lectures and benefit concerts take place in many cities and towns, and the whole week from September 16th to 22nd is dedicated to dementia. A good opportunity to think of those affected and their relatives – and to … Read more

Who was Francisco Lopera, the Alzheimer’s expert who led the research in Latin America? – El Sol de México

by
Who was Francisco Lopera, the Alzheimer’s expert who led the research in Latin America? – El Sol de México

Francisco Lopera Restrepo was a neurologist and professor at the Faculty of Medicine of the University of Antioquia and even founded the Neurosciences Group of Antioquia, making him one of the most important Alzheimer’s researchers in the world. His great performance, in addition to having faced some difficulties, was motivated by his father’s tears and … Read more

Britain is to reject the treatment for early Alzheimer’s launched by the company Eli Lilly

by
Britain is to reject the treatment for early Alzheimer’s launched by the company Eli Lilly

The treatment of the American company Eli Lilly for an early stage of Alzheimer’s disease would be rejected by the National Health Service (NHS) of Great Britain, according to the publication of the Telegraph, cited by Reuters, News.ro transmits. The drug donanemab would be rejected by the National Institute for Health and Care Excellence (NICE), … Read more

Alzheimer’s Association welcomes UK approval of Leqembi but condemns decision to deny NHS access

by
Alzheimer’s Association welcomes UK approval of Leqembi but condemns decision to deny NHS access

CHICAGO, Aug. 23, 2024 /PRNewswire/ — The Alzheimer’s Association welcomes today’s decision by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab) for the treatment of Alzheimer’s disease. However, while celebrating this milestone – the first disease-modifying therapy for Alzheimer’s approved in the UK – the decision by the National Institute … Read more